Relationship between frailty and mortality after gastrectomy in older patients with gastric cancer [0.03%]
胃癌老年患者胃切除术后衰弱与死亡率之间的关系
Ju-Ri Jeong,Ji-Won Choi,Seong-Yeob Ryu et al.
Ju-Ri Jeong et al.
Objectives: Frail older adults with gastric cancer are at an increased risk of poor postoperative outcomes. We assessed whether geriatric frailty assessed using the Study of Osteoporotic Fractures (SOF) index could predic...
Cognitive dysfunction prevalence and associated factors in older breast cancer survivors [0.03%]
老年乳腺癌幸存者的认知功能障碍的患病率及其相关因素
Adele Crouch,Victoria L Champion,Frederick W Unverzagt et al.
Adele Crouch et al.
Objectives: The purpose of this study was to examine the prevalence and factors associated with objective and subjective cognitive dysfunction in older breast cancer survivors (BCS). ...
Physical function before and after initial treatment among older adults with localized or regional stage prostate cancer [0.03%]
局限性或区域前列腺癌老年患者初始治疗前后的体能状态
Jingjing Qian,Chao Li,Cong Bang Truong
Jingjing Qian
The effect of age on health-related quality of life for head and neck cancer patients up to 1 year after curative treatment [0.03%]
年龄对头颈部癌症患者治愈性治疗后一年内健康相关生活质量的影响
Malin Berg,Ewa Silander,Mogens Bove et al.
Malin Berg et al.
Objectives: The aim was to evaluate the effect of age on health-related quality of life (HRQOL) for patients with head and neck cancer (HNC), treated with curative intent, in the Western healthcare region of Sweden. ...
Observational Study
Journal of geriatric oncology. 2022 Jan;13(1):60-66. DOI:10.1016/j.jgo.2021.06.009 2022
Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matching [0.03%]
使用倾向评分匹配评估派姆单抗治疗化疗耐药性尿路上皮癌老年患者的有效性和安全性的研究
Naotaka Nishiyama,Takashi Kobayashi,Shintaro Narita et al.
Naotaka Nishiyama et al.
Background: We used real-world and large-scale data to assess the clinical efficacy and safety of pembrolizumab in older patients with advanced urothelial carcinoma (UC). ...
Targeted agents in older patients with gastrointestinal cancers - An overview [0.03%]
老年胃肠癌症患者的目标疗法概述
Ana Raquel Monteiro,Rita Saúde Conde,Raquel Basto et al.
Ana Raquel Monteiro et al.
Targeted agents have been increasingly used in different malignancies and are associated with improved survival outcomes, including gastrointestinal cancers. Their use in the treatment of older patients is appealing given their favorable to...
When less may be more: Discontinuing docusate from a standardized hospital order set [0.03%]
减少可能意味着更好：标准化医院医嘱集里不再使用都可硫酸钠
Maia von Maltzahn,Rosa Maria Tanzini,Richard Leu et al.
Maia von Maltzahn et al.
Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study) [0.03%]
老年晚期胰腺癌患者接受吉西他滨联合白蛋白结合型紫杉醇的疗效分析——NAPOLION研究的真实世界数据事后分析
Futa Koga,Yasunori Kawaguchi,Mototsugu Shimokawa et al.
Futa Koga et al.
Objectives: This study aimed to examine the efficacy and safety of gemcitabine plus nab-paclitaxel (GnP) in older patients with metastatic pancreatic cancer (MPC), especially those ≥75 years old. ...
Multicenter Study
Journal of geriatric oncology. 2022 Jan;13(1):82-87. DOI:10.1016/j.jgo.2021.06.011 2022
Healthcare utilization and spending among older patients diagnosed with Non-Hodgkin lymphoma [0.03%]
非霍奇金淋巴瘤老年患者的医疗利用和支出状况
Kelly M Kenzik,Grant R Williams,Nickhill Bhakta et al.
Kelly M Kenzik et al.
Background: Developing appropriate care models for patients diagnosed with non-Hodgkin lymphoma (NHL) >65y require examination of current healthcare utilization patterns and cost, but non-malignant condition-specific util...
Predictive Value of Geriatric Oncology Screening and Geriatric Assessment in Older Patients with Solid Cancers: Protocol for a Danish prospective cohort study (PROGNOSIS-G8) [0.03%]
丹麦老年肿瘤筛查和姑息性评估的预测价值(PROGNOSIS-G8)：一项前瞻性队列研究的方案
Helena Møgelbjerg Ditzel,Ann-Kristine Weber Giger,Cecilia Margareta Lund et al.
Helena Møgelbjerg Ditzel et al.
Introduction: Older patients with cancer constitute a heterogeneous group with varying degrees of frailty; therefore, geriatric assessment with initial geriatric oncology screening is recommended. The Geriatric 8 (G8) and...